Drotrecogin alfa (Xigris); Human Activated Protein C; Inj: 5, 20 mg; Patients with severe sepsis with organ dysfunction at high risk of death:
>18 yrs: 2.4 mcg/kg/hr continuous
IV infusion for 96 hrs
Not approved for children <18 yrs.
Contraindications: active bleeding, head trauma.